We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
KISUNLA donanemab 350 mg/20 mL concentrated solution for intravenous infusion vial (420194)
ARTG ID 420194
ARTG Name
KISUNLA donanemab 350 mg/20 mL concentrated solution for intravenous infusion vial
Product name
KISUNLA donanemab 350 mg/20 mL concentrated solution for intravenous infusion vial
ARTG Date
Registration Type
Medicine
Therapeutic good type
Medicines
Sponsor
Ingredients
donanemab
Licence category
RE
Licence status
A
Summary
Product Information
Consumer Medicine Information